Figure 3From: Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients Recurrence free survival in sample set I (n = 63) according the m/z 9198 peak intensity > 20 or ≤ 20, as determined by SELDI-TOF MS.Back to article page